Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/10/2025 | $25.00 | Buy | Needham |
12/16/2024 | Outperform | Macquarie | |
10/11/2024 | $23.00 | Overweight | KeyBanc Capital Markets |
5/30/2024 | $23.00 | Outperform | Robert W. Baird |
4/22/2024 | $25.00 | Buy | Citigroup |
3/6/2024 | $22.00 | Equal Weight | Barclays |
2/26/2024 | $33.00 → $25.00 | Buy | Jefferies |
2/22/2024 | $21.00 | Buy → Neutral | BofA Securities |
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performance For the Three Months Ended September 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $437.9 $417.3 4.9%Gross profit $99.9 $90.6 10
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performance For the Three Months Ended September 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $437.9 $417.3 4.9%Gross profit $99.9 $90.6 10
ARLINGTON, Va., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $176.6 million through the Medicare Shared Savings Program (MSSP) for the 2023 performance year, a 34.1% increase from 2022. The 10 ACOs (collectively, Privia Quality Network or PQN) managed over $2.3 billion in healthcare benchmark spend through approximately 2,850 providers delivering high-value, cost-efficient care to 194,786 Medicare beneficiaries in 2023. "The success of Privia Quality Network in MSSP is a testament to the dedication and skill of our doctors, who provided exceptional care to nearly 195,000
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00
Macquarie initiated coverage of Privia Health with a rating of Outperform
KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us
ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
S-8 - Privia Health Group, Inc. (0001759655) (Filer)
10-Q - Privia Health Group, Inc. (0001759655) (Filer)